Elena discusses the complexities of vaccine development, emphasizing the importance of targeting the receptor binding domain of the spike protein. She outlines the timeline from genetic coding to large-scale production, which can take anywhere from six months to two years, depending on various factors. The conversation highlights the need for parallel efforts in evaluating existing vaccines while new ones are being engineered.
